Filter posts

BIO Patient & Health Advocacy Summit: The Power of Partnerships

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to …

Forbes profiles a medical miracle and the value of cures

This week, Forbes’ Matthew Herper wrote a moving story about a girl who is a …

Ebola Highlights Importance of Vaccine Development in Protecting Global Health

The current Ebola crisis shows how government regulators and research institutions, global health organizations, and …

Kenneth Thorpe: America Subsidizes Medical Innovation for World

Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease and a former deputy assistant …

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

This week, the Center for Medicine in the Public Interest issued a press release criticizing …

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …

Gates Foundation and Grand Challenge Partners Announce New Investments in Breakthrough Science

At an event in Seattle today, the Bill & Melinda Gates Foundation and a group …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …